Registered Kenya · PPB

ZOLPANZ

PANTAPRAZOLE SODIUM

15207 40 MG

What it does

Pantoprazole is a medication that helps reduce the amount of acid your stomach makes.

Commonly used for: stomach ulcers, gastroesophageal reflux disease (GERD), excessive stomach acid production

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
15207
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
PANTAPRAZOLE SODIUM
Dosage form
40 MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Pharma Specialities
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Panari House, Second Floor, P.O. Box 49146, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:57:40 · updated 2026-03-23 04:42:47

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pantoprazole is a medication that helps reduce the amount of acid your stomach makes.

What it treats

  • stomach ulcers
  • gastroesophageal reflux disease (GERD)
  • excessive stomach acid production

How it works

It works by blocking the pumps in the stomach that produce acid, helping to relieve symptoms and heal the stomach lining.

Who it's for

It is for adults and children over 12 years old who have conditions related to stomach acid.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: pantaprazole

Pantoprazole is a proton pump inhibitor (PPI) that decreases the amount of acid produced in the stomach. It is used in the treatment of conditions that involve excessive stomach acid, such as gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome. Pantoprazole is effective in promoting the healing of erosive esophagitis and reducing the risk of ulcer recurrence.

Indications

  • Gastroesophageal reflux disease (GERD)
  • Erosive esophagitis
  • Zollinger-Ellison syndrome
  • Prevention of gastric ulcers
  • H. pylori eradication (in combination therapy)

Dosage

Children: Refer to the BNF for Children for specific dosing information.

Adults: Refer to the BNF for specific dosing information.

Mechanism of action

Pantoprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme system (proton pump) located in the parietal cells of the stomach lining. This inhibition prevents the final step of gastric acid production, leading to a significant reduction in gastric acidity.

Pharmacodynamics

The pharmacodynamic effects of pantoprazole involve a reduction in gastric acid secretion, which can lead to increased gastric pH. This action helps to alleviate symptoms associated with acid-related disorders and promotes healing of the gastric and esophageal mucosa. The onset of action typically occurs within 1 hour, with the maximum effect seen after several days of continuous use.

Pharmacokinetics

Pantoprazole is well absorbed from the gastrointestinal tract, with peak plasma concentrations reached approximately 2 to 4 hours after oral administration. It undergoes extensive hepatic metabolism, primarily via the cytochrome P450 system. The drug has a half-life of about 1 hour; however, its effects can last much longer due to the irreversible inhibition of the proton pump. Pantoprazole is eliminated primarily through urine, with less than 1% of the dose excreted unchanged.

Contra-indications

  • Hypersensitivity to pantoprazole or any of its excipients
  • Concomitant use with rilpivirine-containing products

Adverse effects

  • Headache
  • Dizziness
  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal pain
  • Flatulence
  • Constipation
  • Rash
  • Fatigue
  • Palpitations
  • Bone fractures
  • Kidney injury

Interactions

  • May reduce the absorption of drugs that require an acidic pH for absorption, such as ketoconazole and atazanavir
  • Increased risk of gastrointestinal infections when used with certain antibiotics
  • May interact with warfarin, leading to altered anticoagulation effects

Precautions

  • Long-term use may lead to vitamin B12 deficiency
  • Monitor for signs of Clostridium difficile infection in the colon
  • Caution in patients with liver disease, as dose adjustment may be necessary
  • Use with caution in patients with a history of osteoporosis or fractures

Pregnancy

Limited data on the use of pantoprazole in pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Pantoprazole is excreted in human milk. Caution should be exercised when administering to nursing women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Oral tablets (delayed-release)
  • Intravenous injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.